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Abstract
Pleiotrophin (PTN) is a developmentally-regulated growth factor which is widely distributed in various tissues and also
detected in many kinds of carcinomas. However, little is known about the PTN gene in chickens. In the present study, we
found chicken PTN to be highly conserved with respect to mammalian PTN genes (91–92.6%) and its mRNA was most
abundant in brain, heart and oviduct. This study focused on the PTN gene in the oviduct where it was detected in the
glandular (GE) and luminal (LE) epithelial cells. Treatment of young chicks with diethylstilbesterol induced PTN mRNA and
protein in GE and LE, but not in other cell types of the oviduct. Further, several microRNAs, specifically miR-499 and miR-
1709 were discovered to influence PTN expression via its 39-UTR which suggests that post-transcriptional regulation
influences PTN expression in chickens. We also compared expression patterns and CpG methylation status of the PTN gene
in normal and cancerous ovaries from chickens. Our results indicated that PTN is most abundant in the GE of
adenocarcinoma of cancerous, but not normal ovaries of hens. Bisulfite sequencing revealed that 30- and 40% of 21311
and 21339 CpG sites are demethylated in ovarian cancer cells, respectively. Collectively, these results indicate that chicken
PTN is a novel estrogen-induced gene expressed mainly in the oviductal epithelia implicating PTN regulation of oviduct
development and egg formation, and also suggest that PTN is a biomarker for epithelial ovarian carcinoma that could be
used for diagnosis and monitoring effects of therapies for the disease.
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Introduction
Pleiotrophin (PTN), also known as heparin-binding growth
factor 8 (HBGF-8) and heparin-binding growth associated
molecule (HB-GAM), is a low molecular weight protein (about
18 kDa) which was originally isolated from the bovine uterus [1].
As a member of developmentally regulated cytokine/growth factor
family, it is widely distributed in various tissues and especially plays
pivotal roles in neurogenesis and epithelial mesenchymal interac-
tions through promoting cell growth and migration during early
embryo differentiation and morphogenesis [2,3,4]. PTN binds to
its cognate receptor protein tyrosine phosphatase beta/zeta (RPTP
b/f) [5] and then activates several cytosolic proteins such as
CTNNB1 (beta-catenin), ADD2 (beta-adducin), FYN (Fyn
oncogene related to SRC, FGR, YES) and ALK (anaplastic
lymphoma receptor tyrosine kinase) for many different cellular
functions and systems [4]. In addition, PTN is a proto-oncogene
[6] expressed in malignant tumors and cell lines of various organs
such as breast, prostate, colon, lung and skin and is thought to be
involved in tumor angiogenesis and metastasis [4,7,8,9,10]. In
spite of the fact that PTN is involved in the regulation of cellular
development and differentiation, and the etiology of carcinogen-
esis in many vertebrates, little is known about its expression and
regulation by steroid hormones in the oviduct or its expression in
normal and cancerous ovaries of chickens.
The chicken oviduct is one of best animal models for studies of
organ development and differentiation, and biological actions and
signaling pathways for steroid hormones such as estrogen [11]. As
a representative sex hormone in female reproductive organs,
estrogen not only regulates reproductive behavior but also
stimulates epithelial cells within the immature oviduct to transform
into tubular gland cells via proliferation and cytodifferentiation, as
well as transactivation of oviduct-specific genes such as ovalbumin
during development of the chicken oviduct [12,13]. In addition,
estrogen plays a pivotal role in calcium metabolism and
calicification of the eggshell prior to oviposition in laying hens
[14,15], and exogenous estrogen administration to postnatal chicks
induces cellular hyperplasia and hypertrophy of the oviduct
resulting in its rapid growth rate and maturation [11,16].
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The laying hen is a unique animal model for research on human
ovarian cancer because it spontaneously develops epithelial cell-
derived ovarian cancer as in women [17,18,19,20,21]. Indeed,
ovarian cancer is the most lethal gynecological disease as well as
the 5th leading cause of cancer-derived deaths among women in
the U.S.A. [22,23,24], because it is rarely diagnosed at an early
stage due to the lack of a specific biomarker(s) for early detection
and it is generally asymptomatic [17,25,26]. Among three types of
ovarian cancers, i.e., epithelia-, germ cell-and stroma-derived
malignant tumors [27,28], germinal epithelia-derived ovarian
cancer (EOC) accounts for over 90% of ovarian cancer incidences
in women [29]. This high rate of EOC incidence likely results
from incessant ovulation and menstrual cycles that lead to
genomic damage and mutations in genes in the ovarian surface
epithelium [30,31]. To investigate and elucidate the etiological
and pathological aspects of EOC, several rodent models have been
developed through biotechnological manipulation, but they have
many limitations and obstacle associated with clinical relevance
because of the non-spontaneous nature and physiologically distinct
differences in their EOC [17,32,33]. Meanwhile, the chicken
spontaneously develops EOC at a high rate as occurs in women
and shows very similar morphological characteristics to that of
EOC in women [17,18,19,20,21]. Therefore, the chicken EOC
could be used to develop anti-cancer drugs and biomarkers for
early diagnosis and therapies to prevent adverse outcomes of EOC
in women.
We reported that the avian homolog of the human PTN
transcript is highly expressed in chicks treated with the synthetic
estrogen agonist diethylstilbestrol (DES) [34]. However, little is
known about the expression and function of PTN in most species
except humans and mice [35]. Therefore, the objectives of the
present study were to: 1) investigate tissue- and cell-specific
expression of the PTN gene in chickens; 2) determine whether
estrogen regulates expression of PTN during oviduct development
in chicks; 3) determine whether PTN is regulated by post-
transcriptional actions of specific microRNAs; 4) compare
differential expression of PTN in normal and cancerous ovaries
from hens and 5) examine CpG methylation status in the upstream
promoter region of the PTN gene in normal and cancerous
ovarian cells from hens. Results of current study indicate that PTN
is a novel estrogen-stimulated gene during development of the
chicken oviduct and that it may be a candidate gene for further
research on its role in tumorigenesis leading to EOC in the laying
hen.
Results
Multiple sequence alignment, pairwise comparisons, and
phylogenetic analysis
The PTN gene was found to span 66,234 bp on chicken
chromosome 1 and consists of three exons. PTN mRNA has
2,551 bp encoding a protein with 165 amino acid residues
(Figure 1A). The amino acid sequence of chicken PTN was
compared to those of eight other species. The pair-wise
comparisons of PTN orthologs revealed that chicken PTN protein
is well conserved with high homology relative to other mammalian
PTN proteins (90.9 to 92.6%, Table 1). The phylogenetic tree
constructed with the neighbor-joining method is presented in
Figure 1B. The human and rhesus monkey PTN genes clustered
together and formed a larger cluster with cattle and dog, and an
even larger cluster with sister groups was detected for mouse and
rat. However, chicken PTN is in a separate branch, but closer to
zebrafish than to other species. These results indicate that chicken
PTN diverged from mammalian PTNs at very early stage in its
evolution.
Expression pattern of PTN mRNA in various organs from
chickens
Tissue specific expression of PTN mRNA in brain, heart, liver,
kidney, small intestine, gizzard, ovary, oviduct and testis of 1- to 2-
year-old male (n = 3) and female (n = 3) chickens was determined
by RT-PCR analyses. Results indicated high levels of expression of
PTN mRNA in brain and heart from male and brain, heart,
gizzard and oviduct from female chickens (Figures 1C and 1D),
and lower expression in kidney, gizzard and testis from males and
kidney and ovary from females. However, expression of PTN
mRNA was not detected in other organs analyzed. We reported
differential gene profiling of the chicken oviduct [16] and found
that the avian homolog of the human PTN transcript is highly
expressed in chicks treated with diethylstilbestrol (DES, a synthetic
estrogen agonist). However, little is known about expression and
function of PTN in the oviduct of any species, so this study focused
on the chicken oviduct.
Localization of chicken PTN mRNA and protein in chicken
oviduct
Structurally, the oviduct of egg-laying hens includes the
infundibulum (site of fertilization), magnum (production of
components of egg-white), isthmus (formation of the shell
membrane), and shell gland (formation of the egg shell). Results
of RT-PCR analysis showed abundant level of PTN mRNA in
isthmus and shell gland compared to infundibulum and magnum
(Figure 2A). To determine cell-specific localization of PTN mRNA
in the chicken oviduct, in situ hybridization analysis was
performed. As illustrated in Figure 2B, PTN mRNA was most
abundant in the glandular (GE) and luminal (LE) epithelia of the
isthmus and shell gland, and it was expressed at lower abundance
in GE of the magnum. Little or no mRNA was detected in stromal
cells, blood vessels, immune cells or myometrium of the oviduct. In
addition, results of immunohistochemical analysis (Figure 2C)
were consistent with results from in situ hybridization analyses in
that PTN protein was abundant in LE of the isthmus and shell
gland and also detected, to a lesser extent, in the infundibulum and
magnum. The nonspecific rabbit IgG, used as a negative control,
did not detect any PTN protein.
Effects of DES on PTN mRNA and protein expression in
the chicken oviduct
Cell-type specific expression of PTN in the oviductal segments
of mature hens suggested regulation by estrogen during develop-
ment of the chick oviduct. We reported that administration of
exogenous DES stimulates growth, development and cytodiffer-
entiation of the postnatal chick oviduct and found several
candidate genes and pathways related to the regulation of oviduct
development [16]. Therefore, we examined effects of DES on
PTN expression in the chick oviduct. As illustrated in Figures 3A
and 3B, semi-quantitative RT-PCR analysis indicated that DES
treatment increased PTN mRNA levels in all segments of the chick
oviduct. Further results from quantitative PCR revealed that DES
induced an 8.1-fold increase (P,0.001) in oviductal PTN mRNA
as compared to control chicks (Figure 3C). In addition, DES
stimulated 3.6-, 51.1-, and 6.9-fold increases (P,0.001) in PTN
mRNA in the infundibulum, magnum and isthmus, respectively
(Figure 3D). As shown in Figure 3E, in situ hybridization analyses
revealed that PTN mRNA is expressed specifically in GE and LE
of the magnum and isthmus of chick oviducts treated with DES
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and, at lower abundance in the shell gland and infundibulum.
Consistent with these results, immunoreactive PTN protein was
detected predominantly in GE and LE of magnum and isthmus,
and to a lesser extent, in infundibulum and shell gland (Figure 3F).
Post-transcriptional regulation of microRNAs affecting
PTN
To investigate the possibility that PTN expression is regulated at the
post-transcriptional level by miRNAs, we performed a miRNA target
validation assay. Analysis of potential miRNA binding sites within the
39-UTR for PTN using a miRNA target prediction database (miRDB;
http://mirdb.org/miRDB/) revealed six putative binding site for miR-
499, miR-1555, miR-1632, miR-1709, miR-1787 and miR-1815.
Therefore, we determined if these six miRNAs influenced PTN
expression via its 39-UTR. A fragment of the PTN 39-UTR harboring
binding sites for the miRNAs were cloned downstream of the green
fluorescent protein (GFP) reading frame, thereby creating a fluorescent
reporter for function of the 39-UTR region. After co-transfection of
eGFP-PTN 39-UTR and DsRed-miRNA, the intensity of GFP
expression and percentage of GFP-expressing cells were analyzed by
fluorescence microscopy and FACS. As shown in Figures 4C and 4D,
in the presence of miR-499 and miR-1709, the intensity and percentage
of GFP-expressing cells (21.7% in control vs. 14.1% in miR-499, 16.8%
in miR-1709) decreased (p,0.01). On the other hand, in the presence
of miR-1555, miR-1632, miR-1787 and miR-1815, there was no
significant decrease in green fluorescence as compared to the control
(data not shown). These results indicate that at least two miRNAs
directly bind to the PTN transcript and post-transcriptionally regulate
PTN gene expression.
Figure 1. Multiple sequence alignment and tissue-specific expression of PTN in chickens. [A] The amino acid sequences of PTN from each
of seven species (chicken, human, rhesus monkey, mouse, rat, cattle, dog and zebrafish) are presented based on alignments determined using
Geneious Alignment [76] with BLOSUM (Blocks Substitution Matrix) and gap penalties. Amino acid sequences in the shaded boxes represent those
that are identical among sequences for chicken and mammalian PTN and dashes indicate gaps in the sequences. [B] The phylogenetic tree of PTN
generated from alignments of primary sequences of chicken, human, rhesus monkey, mouse, rat, cattle, dog and zebrafish PTN proteins using
bootstrap analysis with 1,000 replicates. [C and D] Expression of PTN in various organs of male and female of chickens. Results of RT-PCR analysis
using cDNA templates from different organs of male [C] and female [D] chickens with chicken PTN and chicken ACTB-specific primers. See Materials
and Methods for complete description.
doi:10.1371/journal.pone.0034215.g001
Table 1. Pairwise comparison of PTN between chicken and
other species.
Species Symbol Identity (%)
Chicken (Gallus gallus) PTN -
vs. Human (Homo sapiens) PTN 91.4
vs. Rhesus monkey (Macaca mulatta) PTN 91.0
vs. Mouse (Mus musculus) Ptn 92.6
vs. Rat (Rattus norvegicus) Ptn 92.6
vs. Cattle (Bos taurus) PTN 90.9
vs. Dog (Canis lupus familiaris) PTN 91.4
vs. Zebrafish (Danio rerio) ptn 65.4
doi:10.1371/journal.pone.0034215.t001
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Differential expression of PTN in normal and cancerous
ovaries of hens
Chickens are considered the most relevant animal model to
identify and develop biomarkers for patients with epithelial
ovarian cancer because their incessant ovulation increases the
possibility of gene mutations by genomic damage to the ovarian
surface epithelium which can lead to ovarian cancer [30]. We
previously reported expression of cysteine protease cathepin B
(CTSB), serpin peptidase inhibitor, clade B, member 11
(SERPINB11) and alpha 2 macroglobulin (A2M) in ovarian tissue
from hens with ovarian cancer [20,21,36]. Based on similarities
among these genes in expression patterns and estrogen-mediated
Figure 2. Expression of PTN in the chicken oviduct. [A] Results of RT-PCR analysis using cDNA templates from each segment of the chicken
oviduct with chicken PTN and chicken ACTB-specific primers. [B] In situ hybridization analyses of PTN mRNAs in the chicken oviduct. Cross-sections of
the infundibulum, magnum, isthmus and shell gland of the chicken oviduct were hybridized with antisense or sense chicken PTN cRNA probes. [C]
Immunoreactive PTN protein in the chicken oviduct. For the IgG control, normal rabbit IgG was substituted for the primary antibody. Sections were
not counterstained. Legend: LE, luminal epithelium; GE, glandular epithelium. Scale bar represents 100 mm. See Materials and Methods for complete
description.
doi:10.1371/journal.pone.0034215.g002
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Figure 3. Effect of DES on tissue- and cell-specific expression of PTN in the chicken oviduct. Both RT-PCR [A and B] and quantitative-PCR
[C and D] analyses were performed using cDNA templates from DES-treated and control chicken oviducts (mean 6 SEM; P,0.001). These
experiments were was conducted in triplicate and normalized to control GAPDH expression. [E] In situ hybridization analyses indicate cell-specific
expression of PTN mRNA in oviducts of DES-treated and control chicks. Cross-sections of the infundibulum, magnum, isthmus, and shell gland of
oviducts from chicks treated with DES or vehicle were hybridized with antisense or sense chicken PTN cRNA probes. [F] Immunoreactive PTN protein
PTN in the Chicken Oviduct and Ovarian Cancer
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regulation in the oviduct, we hypothesized that expression patterns
for PTN would differ between normal and cancerous ovarian
tissues from hens. Based on RT-PCR analysis, PTN mRNA was
found in all carcinomas, but there was little or no expression in
normal ovaries (Figure 5A and 5B). Further, the level of expression
of PTN mRNA was greater (P,0.001) in cancerous ovaries from
hens (Figure 5C).
Localization of PTN mRNA and protein in cancerous
ovaries of hens
To determine cell-specific expression of PTN mRNA and
protein, in situ hybridization analysis and immunohistochemistry
were performed. As illustrated in Figure 5D, there was abundant
PTN mRNA localized predominantly in GE of cancerous ovaries,
but not in LE, stroma or blood vessels. Consistent with this result,
immunoreactive PTN protein was detected in GE of cancerous
ovaries, but not in any other cell types of the ovaries (Figure 5E).
Furthermore, we determined if the increased expression of PTN in
cancerous tissue was correlated with changes in circulating
concentrations of estradiol in plasma and expression of estrogen
receptor alpha (ESR1) in normal and cancerous ovaries. Even
though in our preliminary experiment we could not detect any
differences in concentrations of estradiol in serum between
cancerous and non-cancerous groups (0.1860.1 ng/ml vs.
0.1760.1 ng/ml), quantitative PCR analysis revealed that ESR1
mRNA levels increased 51-fold (P,0.001) in cancerous ovaries,
but not in normal ovaries (Figure 5F). In addition, immunohis-
tochemical analysis showed that immunoreactive ESR1 was
abundant in the GE of cancerous ovaries (Figure 5G). Little or
no ESR1 was detected in normal ovaries. These results indicate
that PTN abundance increases in response to estrogen in
cancerous ovaries of hens.
Comparison of CpG methylation status in the upstream
of PTN gene between normal and cancerous ovarian cells
in hens
The CpG methylation status in the upstream region of genes
regulates its transcriptional activity and it is closely associated with
in oviducts of DES-treated and control chicks. For the IgG control, normal rabbit IgG was substituted for the primary antibody. Sections were not
counterstained. Legend: LE, luminal epithelium; GE, glandular epithelium. Scale bar represents 100 mm. See Materials and Methods for complete
description.
doi:10.1371/journal.pone.0034215.g003
Figure 4. In vitro target assay of microRNAs on the PTN transcript. [A] Diagram of miR-499 and miR-1709 binding sites in PTN 39-UTR. [B]
Expression vector maps for eGFP with PTN 39-UTR and Ds-Red with each miRNA. The 39-UTR of the PTN transcript was subcloned between the eGFP
gene and the polyA tail to generate the fusion construct of the GFP transcript following the miRNA target 39-UTR (pcDNA-eGFP-39UTR) (upper panel)
and the miRNA expression vector was designed to co-express DsRed and each miRNA (pcDNA-DsRed-miRNA) (lower panel). [C and D] After co-
transfection of pcDNA-eGFP-39UTR for the PTN transcript and pcDNA-DsRed-miRNA for the miR-499 and miR-1709, the fluorescence signals of GFP
and DsRed were detected using FACS [C] and fluorescent microscopy [D]. See Materials and Methods for complete description.
doi:10.1371/journal.pone.0034215.g004
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Figure 5. Quantitation of expression of PTN and ESR1 in normal and cancerous ovaries from hens. [A] RT-PCR analyses were performed
using cDNA templates from normal and cancerous ovaries of laying hens using chicken PTN and ACTB-specific primers. Lanes 1 to 4 show results of
analyses of four normal ovaries. [B] Lanes 1–9 are from analyses of 9 different cancerous ovaries from laying hens. Expression of PTN mRNA was
abundant in all carcinomas, but not in normal ovaries. Legend for panel B: Lane 1, endometrioid/serous/mucinous carcinoma (Stage III); Lane 2,
endometrioid carcinoma (Stage I); Lane 3, serous carcinoma (Stage I); Lane 4, mucinous/endometrioid carcinoma (Stage IV); Lane 5, endometrioid
carcinoma (Stage IV); Lane 6, endometrioid carcinoma (Stage III); Lane 7, clear cell carcinoma (Stage IV); Lane 8, serous/mucinous carcinoma (Stage IV);
and Lane 9, serous/mucinous/endometrioid carcinoma (Stage III) [21]. [C] The q-PCR analysis for PTN mRNA was performed using cDNA templates
from normal and cancerous ovaries of laying hens (mean 6 SEM; P,0.001). [D] In situ hybridization analyses of PTN mRNA in normal and cancerous
ovaries of hens. Cross-sections of normal and cancerous ovaries of hens hybridized with antisense or sense chicken PTN cRNA probes demonstrated
abundant PTNmRNA predominantly in GE of cancerous ovaries, but not in LE, stroma or blood vessels. [E] Immunoreactive PTN protein in normal and
cancerous ovaries of hens. For the IgG control, normal rabbit IgG was substituted for the primary antibody. Sections were not counterstained.
Legend: GE, glandular epithelium. Scale bar represents 200 mm (the first horizontal panels, sense and IgG) or 50 mm (the second horizontal panels,
sense and IgG). [F] The q-PCR analysis for expression of estrogen receptor alpha (ESR1) was performed using cDNA templates from normal and
cancerous ovaries of laying hens (mean 6 SEM; P,0.001). [G] Immunoreactive ESR1 protein in normal and cancerous ovaries of hens. For the IgG
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the initiation and growth of carcinomas. Therefore, we investi-
gated methylation patterns in the promoter region of the PTN
gene in normal and cancerous ovarian epithelial cells. Both
normal and cancerous epithelial cells were extracted and cultured
in vitro as previously reported [37]. Results of bisulfite sequencing
indicated that CpG sites at 21,353 and 21,355 CpG from the
transcriptional start site remained methylated in both normal and
cancerous cells. However, 30- and 40% of 21,339 and 21,311
CpG sites were demethylated in ovarian cancer cells, but not in
normal ovarian epithelial cells (Figure 6A and 6B).
Discussion
Results of the current study are novel in providing the first
comparisons among chicken and mammalian PTN genes with
respect to structure, phylogenetic evolution, tissue specific
expression of PTN mRNA and protein, and regulation of
expression by estrogen in the chicken oviduct. Our results also
revealed that PTN gene expression is post-transcriptionally
regulated by several miRNAs critical to development of the chick
oviduct in response to estrogen. These results support our
hypothesis that PTN is required for growth, development and
functional aspects of the mature oviduct of hens in response to
estrogen during their reproductive cycle. Our previous report on
differential gene profiling of the chick oviduct indicated that the
avian homolog of the human PTN transcript is highly expressed in
chicks treated with DES [34].
The PTN and midkine (MK) proteins are members of a family
of proteins regulating growth and differentiation which share over
50% amino acid sequence identity and their genes are located on
human chromosomes 7q.33 and 11p.11.2, respectively [3,38]. In
chickens, MK (also called retinoic acid-inducible heparin binding
protein) purified from 11-day-old chicken embryos is predomi-
nantly localized within the basement membranes in embryonic
tissues and it stimulates neurite outgrowth and proliferation of
PC12 cells [39,40]. However, little is known about the expression
and function of PTN in chickens. In the present study, multiple
gene sequence alignment showed that the PTN gene in the chicken
genome spans 66,234 bp on chromosome 1 and consists of 3 exons
(2,551 bp mRNA) encoding a protein with 165 amino acid
residues (Figure 1A). The human PTN gene is also about 68 kb
[41], although the human MK genes is only 2 kb [42]. In addition,
results of the present study indicated that chicken PTN protein is
highly conserved with respect to mammalian PTN proteins (90.9
to 92.6%) and that it diverged from mammalian PTN very early in
its evolution.
As illustrated in Figure 1D, PTN mRNA is abundantly
expressed in the chicken oviduct. In mice, the Ptn gene is detected
in a number of tissues and co-localizes with the Mk gene in many
cases during embryogenesis [43]. Although PTN has important
roles in various biological events such as differentiation of renal
tubular epithelial cells and dopaminergic neurons [44,45], Ptn2/2
mice are fertile and exhibit no gross anatomical abnormalities
except for abnormal structure and function of components of the
nervous system [46,47]. Recently, Muramatsu and collegues [56]
reported that mice deficient in both Ptn and Mk were infertile and
had abnormal estrous cycles with long periods of proestrus and
diestrus and short periods of estrus [48]. In addition, the presence
of PTN in the porcine uterus and uterine flushings during early
pregnancy may be a member of the regulators of implantation and
conceptus development [49,50]. In the present study, PTN mRNA
and protein were most abundant in the LE of the isthmus and shell
gland, but detectable at lower abundance in GE in each segment.
As shown in Figure 3, q-PCR analyses revealed that DES induced
oviductal PTN mRNA to a 51.1-fold increase as compared to
control chicks (P,0.001) in the magnum. In chickens, estrogen
stimulates proliferation and cytodifferentiation of immature
oviductal epithelial cells to mature tubular gland cells to activate
egg white protein genes during oviduct development [12,13]. Of
particular note, the fully differentiated tubular gland cells of the
magnum produce and secrete several egg-white proteins such as
ovalbumin, ovomucoid, ovotransferrin and avidin during egg
formation and oviposition [51]. Therefore, the magnum is the
most estrogen-responsive portion of the chicken oviduct that
affects the quality of the egg. These results suggest that the
functional role(s) of PTN in the LE of the magnum is similar with
those in the porcine uterus during early pregnancy.
In a wide variety of fundamental processes and biological events
in vertebrates, such as cellular survival, growth, development and
differentiation, microRNAs (miRNAs) play pivotal roles in post-
transcriptional regulation and pathways [52]. As shown in
Figure 4, co-transfection of eGFP-PTN 39-UTR and DsRed-
miRNA decreased the percentage of GFP-positive cells and GFP
fluorescence density in miR-499 and miR-1709 transfected cells,
but not in cell transfected with miR-1555, miR-1632, miR-1787 and
miR-1815 when compared to controls. These results indicate that
miR-499 and miR-1709 bind directly to the 39-UTR of the PTN
transcript and post-transcriptionally regulate PTN gene transcrip-
tion. Thus, we propose that these two miRNAs are closely related
to the regulatory pathways of oviduct development and differen-
tiation in chickens; however, this requires further investigation.
Results of the present study are the first to identify a high level of
expression of the PTN gene in GE of ovarian carcinoma in laying
hens. Indeed, cancerous ovaries of hens show very similar patterns
of expression of tumor-related genes compared with those in
women [53], and high cross-reactivity and expression of
biomarkers such as CA125, EGFR, and ERBB-2 for human
ovarian cancer [54,55,56,57]. Therefore, laying hens are the most
relevant animal model to identify biomarkers for patients with
epithelial ovarian cancer. Indeed, we found that cathepin B
(CTSB) [20], serpin peptidase inhibitor, clade B, member 11
(SERPINB11) [21] and alpha 2 macroglobulin (A2M) [36] genes
are most abundant in GE of chicken adenocarcinoma. Likewise,
we now report that the PTN gene is expressed predominantly in
GE of the cancerous ovaries from hens. Moreover, we recently
reported that SERPINB3 is a biomarker for chicken ovarian
endometrioid carcinoma and that it can serve as a prognostic
factor for platinum resistance and poor survival in patients with
epithelial ovarian cancer [58]. On the other hand, results of the
the present study revealed differences in the methylation status of
CpG sites in the promoter region of the PTN gene in surface
epithelial cells of cancerous ovaries. In general, a number of genes
are up- and down-regulated in cancer cells of various origins via
DNA methylation and histone modification [59]. These epigenetic
regulatory mechanisms stimulate rates of tumor growthand
metastasis by activation of oncogenes and inactivation of tumor
suppressor genes through differential methylation of genes in the
promoter region [60,61]. In the present study, results of bisulfite
control, normal rabbit IgG was substituted for the primary antibody. Sections were not counterstained. Legend: GE, glandular epithelium. Scale bar
represents 200 mm (the first horizontal panels, sense and IgG) or 50 mm (the second horizontal panels, sense and IgG). See Materials and Methods for a
complete description of the methods.
doi:10.1371/journal.pone.0034215.g005
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sequencing revealed that 30- and 40% of 21,339 and 21,311
CpG sites were demethylated in ovarian cancer cells, but not in
normal ovarian epithelial cells (Figure 6). This different metylation
status from between normal and cancerous ovarian cells likely
affects development of cancer phenotypes. In addition, expression
of the PTN gene may be epigenetically regulated, and its cell type
specific expression closely associated with DNA methylation. As
illustrated in Figure 6C, the position of the 21,339 CpG site is
located within the putative binding elements for the upstream
stimulatory factor (USF also known as gamma-factor). Further-
more, we compared the 59 flanking region (about 2.2 kb) of mouse
and human PTN with that of chicken PTN to identify differences
in sequences around CpG sites and found one CpG site in mouse,
but not in human. However, further research is required to
elucidate the relationship between PTN and USF signaling
cascades in cancerous ovaries of hens. These results support our
hypothesis that PTN is a critical regulator for growth and
developmental aspects of epithelial cells of the ovaries of laying
hens as they transition from a normal to a cancerous state. In
humans, the PTN gene is involved in carcinogenesis including
mitogenesis, metastasis and angiogenesis, and it is expressed in a
variety of cancers, such as lung [10,62], colon [63], prostate [8],
breast [7] and pancreas [64] as well as melanomas [9],
neuroblastomas [65] and many carcinoma cell lines. It is thought
that PTN is an angiogenic factor thatstimulates tumor growth and
metastasis. For instance, nude mice implanted with breast cancer
cells and treated with dominant negative PTN showed a significant
decrease in the rates of tumor growth and angiogenesis [66],
whereas mice overexpressing PTN in breast cancer cells showed
increased levels of tumor growth, microvessel density and
Figure 6. Bisulfite sequencing of CpG sites in the upstream region of the PTN gene. [A] Schematic of the four CpG sites in the promoter
region of the PTN gene are indicated by the heavy black vertical lines. The numbers on the line indicate positions relative to the transcription start
site. Legend: a, complex contains E2F and p107 (E2F+p107); b, upstream stimulatory factor (USF also known as gamma-factor). [B] The CpG
methylation status in the upstream region of the PTN gene was analyzed in normal and ovarian cancer cells from hens by bisulfate sequencing. Each
circle indicates a CpG site in the primary sequence, and each line of circles represents analysis of a single cloned allele. Closed and open circles are
methylated and unmethylated CpGs, respectively. [C] Comparison of the sequences around CpG regions of PTN genes of chicken, mouse, and human.
The 59 flanking region (about 2.2 kb) of mouse and human PTN was compared to that of chicken PTN to identify differences in sequences around
each CpG sites among those species.
doi:10.1371/journal.pone.0034215.g006
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endothelial cell proliferation [67]. These results indicate that PTN
secreted from tumor cells stimulate proliferation and tube
formation of endothelial cells [4].
Collectively, results of the present study indicate that PTN is a
novel estrogen-stimulated gene during growth, development and
differentiation of the chicken oviduct and that it is likely a critical
regulator of abnormal growth and functional aspects of ovarian
surface epithelial cells as they transition from normal to a
cancerous state in laying hens. These results also provide
important insight into future research to investigate the precise
role(s) and signal transduction cascades involving PTN. Research
will be directed toward understanding mechanisms responsible for
estrogen-mediated development and cytodifferentiation of cells of
the chicken oviduct and the significance of PTN as a biomarker of
epithelial ovarian cancer of laying hens to elucidate the etiologies
and pathogenesis of the disease.
Materials and Methods
Experimental Animals and Animal Care
The experimental use of chickens for this study was approved by
the Institute of Laboratory Animal Resources, Seoul National
University (SNU-070823-5). White Leghorn (WL) laying hens and
chicks were subjected to standard management practices at the
University Animal Farm, Seoul National University, Korea. The
management, reproduction, and embryo manipulation procedures
adhered to standard operating protocols of our laboratory. All
chickens were exposed to a light regimen of 15 h light and 9 h
dark with ad libitum access to feed and water.
Tissue Samples
Study one. Following euthanasia of mature WL hens, tissue
samples were collected from brain, heart, liver, kidney, small
intestine, gizzard, ovary, oviduct and testis of 1- to 2- year-old
males (n = 3) and females (n = 3). Subsets of these samples were
frozen or fixed in 4% paraformaldehyde for further analyses.
Frozen tissue samples were cut into 5- to 7-mm pieces, frozen in
liquid nitrogen vapor, and stored at 280uC. The other samples
were cut into 10 mm pieces and fixed in fresh 4%
paraformaldehyde in PBS (pH 7.4). After 24 h, fixed tissues
were changed to 70% ethanol for 24 h and then dehydrated and
embedded in Paraplast-Plus (Leica Microsystems, Wetzlar,
Germany). Paraffin-embedded tissues were sectioned at 5 mm.
Study two. Female chicks were identified by PCR analysis
using W chromosome-specific primer sets [68]. Treatment with
DES and recovery of the oviduct were conducted as reported
previously [69,70]. Briefly, a 15 mg DES pellet was implanted
subcutaneously in the abdominal region of 1-week-old female
chicks for release of hormone for 20 days [69,71,72]. Five chicks in
each group were euthanized using 60%–70% carbon dioxide.
Subsets of these samples were frozen or fixed in 4%
paraformaldehyde for further analyses. Frozen tissue samples
were cut into 5- to 7-mm pieces and frozen in liquid nitrogen. The
other samples were cut into 10- to 15-mm pieces and fixed in fresh
4% paraformaldehyde in PBS (pH 7.4). After 24 h, fixed tissues
were changed to 70% ethanol for 24 h and then dehydrated and
embedded in Paraplast-Plus (Leica Microsystems, Wetzlar,
Germany). Paraffin-embedded tissues were sectioned at 5 mm.
Study three. In this study, a total of 136 chickens (88
chickens over 36 months of age and 48 chickens over 24 months of
age), which had completely stopped laying eggs were euthanized
for biopsy and cancerous (n = 10) ovaries were collected. As a
control, normal (n = 5) ovaries were also collected from egg-laying
hens. We examined tumor stage in 10 hens with cancerous ovaries
based on characteristic features of chicken ovarian cancers [17]. In
three hens, ovarian tumor cells were classified as Stage III as they
had metastasized to the gastrointestinal tract and superficial
surface of the liver with profuse ascites in the abdominal cavity. In
five hens, the tumors had metastasized to distant organs such as
liver parenchyma, lung, gastrointestinal tract and oviduct with
profuse ascites, so these were classified at Stage IV tumors. The
other two hens did not have tumors in any other organs; therefore,
their ovarian tumors were classified as Stage I. Subsets of these
samples were frozen or fixed in 4% paraformaldehyde for further
analyses. Frozen tissue samples were cut into 5- to 7-mm pieces
and frozen in liquid nitrogen. The other samples were cut into
10 mm pieces and fixed in 4% paraformaldehyde in PBS (pH 7.4).
After 24 h, fixed tissues were changed to 70% ethanol for 24 h and
then dehydrated and embedded in Paraplast-Plus (Leica
Microsystems, Wetzlar, Germany). Paraffin-embedded tissues
were sectioned at 5 mm and stained with hematoxylin and eosin.
Epithelial ovarian cancers in chickens were classified based on
their cellular subtypes and patterns of cellular differentiation with
reference to ovarian malignant tumor types in humans [17].
RNA Isolation
Total cellular RNA was isolated from frozen tissues using Trizol
reagent (Invitrogen, Carlsbad, CA) according to manufacturer’s
recommendations. The quantity and quality of total RNA was
determined by spectrometry and denaturing agarose gel electro-
phoresis, respectively.
Semiquantitative RT-PCR analysis
The expression of PTN mRNA in normal and cancerous ovaries
of chickens, was assessed using semi-quantitative RT-PCR as
described previously [73]. The cDNA was synthesized from total
cellular RNA (2 ug) using random hexamer (Invitrogen, Carlsbad,
CA) and oligo (dT) primers and AccuPowerH RT PreMix
(Bioneer, Daejeon, Korea). The cDNA was diluted (1:10) in sterile
water before use in PCR. For PTN, the sense primer (59-TGC
TCT CCT GGC ACT TGT CT-39) and antisense primer (59-
CTT GGA TTC TTG AGG TTT GGG-39) amplified a 414-bp
product. For ACTB (housekeeping gene; beta-actin), the sense
primer (59-GTG TGA TGG TTG GTA TGG GC-39) and
antisense primer primer (59-TTT CTC TCT CGG CTG TGG
TG-39) amplified a 498-bp product. The primers, PCR amplifi-
cation and verification of their sequences were conducted as
described previously [73]. PCR amplification was conducted using
approximately 60 ng cDNA as follows: (1) 95uC for 3 min; (2)
95uC for 20 sec, 60uC for 40 sec (for PTN and ACTB) and 72uC
for 1 min for 35 cycles; and (3) 72uC for 10 min. After PCR, equal
amounts of reaction product were analyzed using a 1% agarose
gel, and PCR products were visualized using ethidium bromide
staining. The amount of DNA present was quantified by
measuring the intensity of light emitted from correctly sized bands
under ultraviolet light using a Gel DocTM XR+ system with Image
LabTM software (Bio-Rad).
Quantitative RT-PCR Analysis
Total RNA was extracted from each sample of normal and
cancerous ovarian tissue from hens using TRIzol (Invitrogen) and
purified using an RNeasy Mini Kit (Qiagen). Complementary
DNA was synthesized using AccuPowerH RT PreMix (Bioneer,
Daejeon, Korea). Gene expression levels were measured using
SYBRH Green (Sigma, St. Louis, MO, USA) and a StepOne-
PlusTM Real-Time PCR System (Applied Biosystems, Foster City,
CA, USA). The GAPDH gene was simultaneously analyzed as a
control and used for normalization for variation in loading. Each
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target gene and GAPDH was analyzed in triplicate. Using the
standard curve method, we determined the level of expression of
the examined genes using the standard curves and CT values, and
normalized them using GAPDH expression quantities. The PCR
conditions were 95uC for 3 min, followed by 40 cycles at 95uC for
30 sec, 60uC for 30 sec, and 72uC for 30 sec using a melting curve
program (increasing the temperature from 55uC to 95uC at a rate
of 0.5uC per 10 sec) and continuous fluorescence measurement.
ROX dye (Invitrogen) was used as a negative control for the
fluorescence measurements. Sequence-specific products were
identified by generating a melting curve in which the CT value
represented the cycle number at which a fluorescent signal was
statistically greater than background, and relative gene expression
was quantified using the 22DDCT method [74]. For the control, the
relative quantification of gene expression was normalized to the
CT of the control oviduct.
In Situ Hybridization Analysis
For hybridization probes, PCR products were generated from
cDNA with the primers used for RT-PCR analysis. The products
were gel-extracted and cloned into TOPOH vector (invitrogen).
After verification of the sequences, plasmids containing the correct
gene sequences were amplified with T7- and SP6-specific primers
(T7:59-TGT AAT ACG ACT CAC TAT AGG G-39; SP6:59-
CTA TTT AGG TGA CAC TAT AGA AT-39) then digoxigenin
(DIG)-labeled RNA probes were transcribed using a DIG RNA
labeling kit (Roche Applied Science, Indianapolis, IN). Tissues
were collected and fixed in 4% paraformaldehyde, embedded in
paraffin and sectioned at 5 mm on APES-treated (silanized) slides.
The sections were then deparaffinized in xylene and rehydrated to
diethylpyrocarbonate (DEPC)-treated water through a graded
series of alcohol. The sections were treated with 1% Triton X-100
in PBS for 20 min and washed two times in DEPC-treated PBS.
After washing in DEPC-treated PBS, they were digested with
5 mg/ml proteinase K (Sigma) in TE buffer (100 mM Tris-HCl,
50 mM EDTA, pH 8.0) at 37uC. After postfixation in 4%
paraformaldehyde, sections were incubated twice for 5 min each
in DEPC-treated PBS and incubated in TEA buffer (0.1M
triethanolamine) containing 0.25% (v/v) acetic anhydride. The
sections were incubated in a prehybridization mixture containing
50% formamide and 46 standard saline citrate (SSC) for at least
10 min at room temperature. After prehybridization, the sections
were incubated with a hybridization mixture containing 40%
formamide, 46 SSC, 10% dextran sulfate sodium salt, 10 mM
DTT, 1 mg/ml yeast tRNA, 1 mg/ml salmon sperm DNA,
0.02% Ficoll, 0.02% polyvinylpyrrolidone, 0.2 mg/ml RNase-free
bovine serum albumin and denatured DIG-labeled cRNA probe
for overnight at 42uC in a humidified chamber. After hybridiza-
tion, sections were washed for 15 min in 26SSC at 37uC, 15 min
in 16SSC at 37uC, 30 min in NTE buffer (10 mM Tris, 500 mM
NaCl and 1 mM EDTA) at 37uC and 30 min in 0.16 SSC at
37uC. After blocking with a 2% normal sheep serum (Santa Cruz
Biotechnology, INC.), the sections were incubated overnight with
sheep anti-DIG antibody conjugated to alkaline phosphatase
(Roche). The signal was visualized by exposure to a solution
containing 0.4 mM 5-bromo-4-chloro-3-indolyl phosphate,
0.4 mM nitroblue tetrazolium, and 2 mM levamisole (Sigma).
Immunohistochemistry
Immunocytochemical localization of PTN protein in normal
and cancerous ovaries from chickens was performed as described
previously [75] using a rabbit polyclonal antibody to PTN
(Catalog number ab-95391; AbCam, CA, USA) and a rabbit
antiserum to ESR1 (Catalog number E0646; Sigma-Aldrich, St.
Louis, MO, USA) at a final dilution of 1:200 (0.2 mg/ml) and
1:100 (0.2 mg/ml), respectively. Antigen retrieval was performed
using the boiling citrate method for PTN and Pronase E digestion
for ESR1 as described previously [75]. Negative controls included
substitution of the primary antibody with purified non-immune
rabbit IgG at the same final concentration.
Prediction of Transcription Factor-Binding cis-Elements
The presence of transcription factor-binding cis-elements within
the PTN promoter region was predicted using a bioinformatics
tool for orthologous sequences (TFSEARCH ver. 1.3; http://
www.cbrc.jp/research/db/TFSEARCH.html).
Bisulfite Sequencing
DNA samples were prepared using an AccuPrep Genomic
DNA Extraction Kit (Bioneer) and converted using Epitect
Bisulfite kit (QIAGEN, Doncaster, Australia) according to the
manufacturer’s instructions. For amplifying the converted DNA,
PCRs were performed with forward (5-GGA TTT TTG TGT
AAA TTT GGA GTA G-3) and reverse (5-TTC CAA AAT CCA
AAC AAT TTC TAT C-3) primers, which included the upstream
region of the PTN gene, as follows: 95uC for 3 min, 35 cycles at
95uC for 1 min, 56uC for 1 min, 72uC for 2 min, and 72uC for
5 min for the final synthesis. The PCR products were cloned into
the pGEM-T easy vector (Promega, Madison, WI) and sequenced
using an ABI Prism 3730 XL DNA Analyzer (Applied Biosystems,
Foster City, CA).
MicroRNA Target Validation Assay
The 39-UTR of PTN was cloned and confirmed by sequencing.
The 39-UTR was subcloned between the eGFP gene and the
bovine growth hormone (bGH) poly-A tail in pcDNA3eGFP
(Clontech, Mountain View, CA) to generate the eGFP-miRNA
target 39-UTR (pcDNA-eGFP-39UTR) fusion constructs. For the
dual fluorescence reporter assay, the fusion constructs containing
the DsRed gene and either miR-499, miR-1555, miR-1632, miR-
1709, miR-1787 or miR-1815 were designed to be co-expressed
under control of the CMV promoter (pcDNA-DsRed-miRNA).
The pcDNA-eGFP-39UTR and pcDNA-DsRed-miRNA (4 mg)
were co-transfected into 293FT cells using the calcium phosphate
method. When the DsRed-miRNA is expressed and binds to the
target site of the 39-UTR downstream of the GFP transcript, green
fluorescence intensity decreases due to degradation of the GFP
transcript. At 48 h post-transfection, dual fluorescence was
detected by fluorescence microscopy and calculated by FACSCa-
libur flow cytometry (BD Biosciences). For flow cytometry, the
cells were fixed in 4% paraformaldehyde and analyzed using
FlowJo software (Tree Star Inc., Ashland, OR).
Statistical Analyses
Data presented for real-time PCR are expressed as mean 6
SEM unless otherwise stated. Differences in the variances between
normal and cancerous ovaries were analyzed using the F test, and
differences between means were subjected to the Student’s t test.
Differences with a probability value of P,0.05 were considered
statistically significant. Excel (Microsoft, Redmond, WA, USA)
was used for statistical analyses.
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